Introduction {#s1}
============

Housed in the inner ear cochlea, the auditory sensory organ contains a spiral shaped sensory epithelium specialized to detect and transduce sound. Along its longitudinal axis, two types of mechano-sensory cells, referred to as inner and outer hair cells, are arranged in distinct rows, with three rows of outer hair cells and a single row of inner hair cells. To ensure the highly stereotyped arrangement of hair cells, cell cycle withdrawal and differentiation within the auditory sensory epithelium occurs in a spatially and temporally highly coordinated manner. Auditory sensory progenitors (pro-sensory cells) exit the cell cycle in an apical-to-basal gradient ([@bib11]; [@bib28]; [@bib47]), whereas their differentiation into hair cells and supporting cells occurs in an opposing, basal-to-apical gradient ([@bib11]). Recent studies uncovered that Sonic Hedgehog (SHH) signaling plays a key role in setting up the spatial and temporal pattern of auditory hair cell differentiation. In the undifferentiated cochlea, pro-sensory cells are exposed to high concentrations of SHH protein secreted by the adjacent spiral ganglion neurons (SGNs) ([@bib7]; [@bib32]). SGN-specific ablation of SHH or cochlear epithelial-specific ablation of its co-receptor Smoothened results in premature hair cell differentiation and in the most extreme case a reversal of the gradient of hair cell differentiation ([@bib7]; [@bib53]). The basic-helix-loop-helix (bHLH) transcription factor ATOH1 is the earliest marker of nascent hair cells and is both necessary and sufficient for the production of hair cells ([@bib6]; [@bib8]; [@bib58]; [@bib59]). SHH signaling represses hair cell differentiation, at least in part, through maintaining the expression of HEY1 and HEY2 in pro-sensory cells ([@bib5]; [@bib53]). The bHLH transcriptional repressors HEY1 and HEY2 have been shown to antagonize ATOH1 function ([@bib14]) and their loss leads to premature hair cell differentiation ([@bib5]). In addition to HEY1 and HEY2, auditory pro-sensory cells express members of the inhibitor of differentiation (ID) family ([@bib24]). ID proteins are dominant negative regulators of bHLH transcription factors (reviewed in [@bib56]). Acting downstream of BMP signaling, ID1-3 are thought to maintain pro-sensory cells in an undifferentiated state by interfering with ATOH1's ability to bind to DNA and auto-regulate its own expression ([@bib24]; [@bib25]). Through a yet unknown mechanism, *Id1-3* expression is downregulated in a subset of pro-sensory cells at the onset of differentiation, allowing these cells to upregulate ATOH1 and to differentiate into hair cells.

Much less is known about the signals and factors that promote ATOH1 expression/activity within pro-sensory cells and their role in auditory hair cell differentiation. Over-activation of Wnt/β-catenin signaling has been shown to increase *Atoh1* expression in differentiating cochlear explants, and in the absence of Wnt/β-catenin signaling hair cells fail to form ([@bib23]; [@bib40]) ([@bib50]). However, the pattern of Wnt--reporter activity, which at the onset of hair cell differentiation is high in the cochlear apex but low in the cochlear base, does not parallel the basal-to-apical wave of differentiation ([@bib23]). Interestingly, the *Inhba* gene, which encodes the Activin A subunit Inhibin βA ([@bib1]), has been recently reported to be expressed in a basal-to-apical gradient within the differentiating auditory sensory epithelium ([@bib52]). Activins, which belong to the transforming growth factor (TGF)-β superfamily of cytokines, control a broad range of biological processes, including reproduction, embryonic axial specification, organogenesis and adult tissue homeostasis (reviewed in [@bib41]). Canonical TGFβ-type signaling is transduced by receptor regulated SMAD proteins (R-SMADs). Upon receptor mediated phosphorylation, R-SMADs (SMAD1, 2, 3, 5, 9) form heteromeric complexes with SMAD4, which enables them to translocate to the nucleus and activate a broad array of target genes (reviewed in [@bib36]). In the developing spinal cord, Activins and other TGF-β-related ligands are required in most dorsally located neuronal progenitors for *Atoh1* induction and their subsequent differentiation as D1A/B commissural neurons ([@bib27]; [@bib57]). The role of Activin-type signaling in cochlear *Atoh1* regulation and hair cell differentiation is currently unknown.

Here, we identify Activin A and its antagonist follistatin (FST) as key regulators of *Atoh1* gene expression and hair cell differentiation. We find that in the developing murine cochlea Activin A acts as a pro-differentiation signal, and demonstrate that a counter gradient of Activin A and FST within the auditory sensory epithelium times the basal-to-apical wave of hair cell differentiation. Furthermore, we provide evidence that a counter gradient of Activin A and FST informs a previously unidentified medial-to-lateral gradient of terminal mitosis that forces inner hair cell progenitors located at the medial edge of the sensory epithelium to withdraw from the cell cycle prior to outer hair cell progenitors.

Results {#s2}
=======

The graded pattern of Activin A expression parallels auditory hair cell differentiation {#s2-1}
---------------------------------------------------------------------------------------

The biological activity of Activins and other Activin-type ligands is limited by the secreted protein follistatin (FST). Two FST molecules encircle the Inhibin β dimer, blocking both type I and type II receptor binding sites, thus preventing receptor binding and activation of its downstream signaling cascade ([@bib54]). Within the differentiating auditory sensory epithelium *Fst* and the Inhibin βA encoding gene *Inhba* are expressed in opposing gradients, with *Inhba* being highest expressed within the basal sensory epithelium and *Fst* being highest expressed apically ([@bib52]). To explore a potential correlation with hair cell differentiation we analyzed the pattern of *Atoh1, Inhba* and *Fst* mRNA expression in the developing cochlea stages E13.5-E15.5 ([Figure 1A--C](#fig1){ref-type="fig"}). In mice, *Atoh1* expression starts around embryonic stage E13.5-E14.0 in a subset of *Sox2* positive pro-sensory cells at the basal turn of the cochlea ([Figure 1A](#fig1){ref-type="fig"}). Paralleling *Atoh1* expression, *Inhba* expression was limited to the basal pro-sensory domain. In contrast, *Fst* was highly expressed within the lateral part of the pro-sensory domain throughout the cochlear apex and mid turn but was only weakly expressed in the cochlear base. At stages E14.5 and E15.5, as hair cell differentiation progressed towards the cochlear apex, *Inhba* expression within the pro-sensory/sensory domain extended to the cochlear mid-turn ([Figure 1B,C](#fig1){ref-type="fig"}). At the same time, *Fst* expression further regressed in the cochlear base and weakened in the cochlear mid-turn but continued to be highly expressed in the undifferentiated cochlear apex.

![Activin A expression parallels auditory hair cell differentiation.\
(**A-C**) In situ hybridization (ISH) was used to analyze the cochlear expression pattern of *Inhba* and *Fst* at the onset of (A, E13.5) and during hair cell differentiation (B, E14.5 and C, E15.5) in adjacent serial cochlear sections. *Sox2* transcript marks the pro-sensory/sensory domains, *Atoh1* transcript marks nascent hair cells. Brackets mark the pro-sensory/sensory domains with the cochlear duct. Abbreviations: m, medial; l, lateral. Scale bar, 100 µm. (**D**) Schematics of longitudinal (apical--basal) and radial (medial-lateral) expression gradients of *Inhba* (green) and *Fst* (red) within the auditory sensory epithelium.](elife-47613-fig1){#fig1}

As summarized in [Figure 1D](#fig1){ref-type="fig"}, our analysis of *Inhba* and *Fst* expression suggests that pro-sensory cells in the differentiating cochlea are exposed to an Activin A signaling gradient that closely resembles the spatial and temporal pattern of hair cell differentiation.

Activin A promotes precocious cochlear hair cell differentiation {#s2-2}
----------------------------------------------------------------

Activins play a central role in coordinating growth and differentiation in sensory and neuronal tissues, including the retina, olfactory epithelium and spinal cord ([@bib13]; [@bib17]; [@bib31]). To determine the role of Activin A in auditory hair cell differentiation, we exposed undifferentiated cochlear tissue (stage E13.5) to recombinant Activin A for 24 hours (hr) ([Figure 2A](#fig2){ref-type="fig"}). As a readout for hair cell differentiation we used transgenic cochlear tissue that expressed nuclear localized green fluorescent protein (GFP) under the control of the *Atoh1* enhancer ([@bib33]). Hair cell differentiation follows a steep basal-to-apical gradient in which hair cells located within the cochlear mid-basal segment differentiate prior to more apically located hair cells. In addition, a shallower, medial-to-lateral gradient exists, with inner hair cells differentiating prior to their neighboring more laterally located outer hair cells ([@bib11]). After 12 hr of culture, control cultures showed no or only weak *Atoh1-GFP*-reporter activity (GFP) within the developing cochlear duct ([Figure 2B](#fig2){ref-type="fig"}, *Control*, 12 hr). By contrast, a narrow stripe of GFP positive inner hair cells was already evident in Activin A-treated cochlear explants ([Figure 2B](#fig2){ref-type="fig"}, *Activin A*, 12 hr). 6 hr later, a broad stripe of GFP positive cells representing inner and outer hair cells was present in Activin A-treated cochlear explants, whereas control cochlear explants contained only few scattered GFP positive inner hair cells ([Figure 2B](#fig2){ref-type="fig"}, 18 hr). Furthermore, at all stages examined, the band of GFP positive cells extended further apically in Activin A-treated cochlear explants compared to control cochlear explants ([Figure 2B,C](#fig2){ref-type="fig"}). Taken together, our findings indicate that Activin A acts a differentiation signal for auditory hair cells.

![Activin A promotes auditory hair cell differentiation.\
(**A**) Experimental design for B-D. Stage E13.5 wild type cochlear explants were cultured with or without Activin A (final conc. 500 ng/ml) for 24 hr. (**B**) *Atoh1-GFP* reporter expression (GFP, gray) was used to monitor and analyze hair cell differentiation in Activin A-treated and control cochlear explants. Asterisks mark the vestibular saccule that contain GFP positive hair cells. Yellow arrows mark the onset of hair cell differentiation within the cochlea. Scale bar, 100 µm. (**C**) Quantification of basal-to-apical extent of hair cell differentiation in control versus Activin A-treated cochlear cultures (**B**). Data expressed as mean ± SEM (n = 5--8 cochlear explants per group, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001, student's t-test). (**D**) Transcript levels of pro-sensory genes (*Id1-4, Hey1, Hey2,* p27*, Etv5, Fgf20, Ptch1*) and hair cell-specific genes (*Atoh1, Pou4f3*) were analyzed in enzymatically purified cochlear epithelia. Data are mean ± SEM (n = 3 biological replicates, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, student's t-test). (**E**) Experimental design for F, G. Stage E13.5 wild type cochlear epithelia were cultured with or without Activin A (final conc. 200 ng/ml) or BMP4 (final conc. 100 ng/ml) for 3.5 hr. (**F**) RT-qPCR analysis reveals differential response to Activin A and BMP4 treatment. Individual cochlear epithelia were analyzed. Data are mean ± SEM, n = 4 biological replicates, \*p\<0.05. (**G**) Activin A induces SMAD2/3 phosphorylation in cochlear epithelial cells. Western blot analysis was used to detect phosphorylated (p) SMAD2/3 and p-SMAD1/5/9 proteins in individual cochlear epithelia after 3.5 hr culture with or without Activin A or BMP4. Beta-actin was used as loading control.](elife-47613-fig2){#fig2}

To identify downstream targets of Activin signaling in the developing cochlea, we cultured E13.5 cochlear explants with or without Activin A for 24 hr, after which we enzymatically purified the corresponding cochlear epithelia and performed RT-qPCR ([Figure 2D](#fig2){ref-type="fig"}). Our analysis focused on known effectors of hair cell differentiation and their upstream regulators. We found that Activin A treatment increased the expression of *Atoh1* and the Wnt-target gene *Lgr5* by more than 4-fold and increased the expression of *Pou4f3*, a critical early hair cell-specific transcription factor by more than 12-fold. Furthermore, Activin treatment led to a more than 2-fold reduction in *Bmp4, Id2, Id3 and Id4* expression, but did not significantly alter the expression of other pro-sensory genes (p27/Kip1- official gene name *Cdkn1b, Etv5, Hey1*, *Hey2*, *Fgf20* and *Ptch1)*.

BMP receptor signaling has been shown to positively regulate *Id1-3* expression in cochlear and vestibular pro-sensory cells ([@bib25]; [@bib42]). However, the role of BMP signaling in cochlear *Id4* gene expression has not yet been established. To further characterize the role of BMP and Activin signaling in *Atoh1* and *Id* gene regulation, we cultured enzymatically purified cochlear epithelia for 3.5 hr in the presence of either Activin A, BMP4 or vehicle control ([Figure 2E](#fig2){ref-type="fig"}). Brief BMP4 treatment significantly increased *Id1 and Id3* expression compared to control but had no effect on *Id4 and Atoh1* expression ([Figure 2F](#fig2){ref-type="fig"}). Conversely, the brief Activin A treatment resulted in a modest, but significant decrease in *Id4* expression compared to control but did not alter *Id1-3* or *Atoh1* expression ([Figure 2F](#fig2){ref-type="fig"}). The divergent transcriptional responses to Activin A and BMP4 treatment are likely the consequence of differences in R-SMAD utilization. Activation of Activin signaling commonly leads to the phosphorylation and activation of SMAD2 and SMAD3, whereas stimulation of BMP signaling leads to the phosphorylation and activation of SMAD1, SMAD5 and SMAD9 (reviewed in [@bib39]). Indeed, we found that in the developing cochlea Activin A selectively stimulated the phosphorylation of SMAD2/3, whereas BMP4 treatment selectively induced the phosphorylation of SMAD1/5/9 ([Figure 2G](#fig2){ref-type="fig"}).

Taken together these findings suggests that Activin A positively regulates *Atoh1* expression through an indirect mechanism that, at least in part, involves the repression of BMP-dependent and independent *Id* gene expression.

FST overexpression delays cochlear hair cell differentiation {#s2-3}
------------------------------------------------------------

To characterize the function of FST in cochlear development we made use of a previously developed doxycycline (dox) inducible transgenic mouse line, in which a cassette encoding the human FST-288 isoform is under the control of a tetracycline-responsive promoter element (tetO) ([@bib30]; [@bib46]) ([Figure 3A](#fig3){ref-type="fig"}). In the presence of a ubiquitously expressed reverse tetracycline-controlled trans-activator (rtTA), dox administration allows for robust induction of the human (h) FST transgene ([Figure 3A,B](#fig3){ref-type="fig"}). To assess the role of FST in cochlear hair cell differentiation, timed pregnant females received dox beginning at E11.5 and double transgenic FST over-expressing embryos (*R26-FST*) and single transgenic littermates lacking the R26-M2rtTA transgene (control) were harvested three days later (E14.5). Inclusion of the *Atoh1*-reporter transgene (*Atoh1-GFP*) allowed for the ready analysis of hair cell differentiation at the time of isolation. While control cochlear tissue already contained inner hair cells at the base of the cochlea, as shown here using cochlear whole mounts and sections, FST overexpressing cochlear tissue still lacked hair cells ([Figure 3C,D](#fig3){ref-type="fig"}).

![FST overexpression interferes with auditory hair cell differentiation.\
(**A**) Inducible *FST* transgenic mouse model. In the presence of doxycycline (dox) double transgenic animals (*R26-M2rtTA* and *tetO-human FST*) express human FST under the control of the R26 promoter (*R26-FST*). Non-transgenic littermates and littermates that carry only one of the transgenes were used as experimental controls (Ctrl). (**B**) Human (h) *FST* transgene expression in control (Ctrl) and *R26-FST* transgenic (FST) cochlear epithelia after 48 hr of dox administration. Plotted is the difference in cycle threshold (ΔCT) compared to the reference gene *Rpl19*. Data expressed as mean ± SEM (n = 4 animals per group, \*\*\*p≤0.001, student's t-test). (**C**) Low power fluorescent images showing native *Atoh1-GFP* reporter expression (GFP, gray) in wild type (control) and FST overexpressing (*R26-FST*) cochleae stage E14.5. Asterisks mark the vestibular saccule that contain GFP positive hair cells. Yellow arrows mark the onset of hair cell differentiation within the cochlea. Scale bar 100 µm. (**D**) Confocal images of wild type (control) and FST overexpressing (*R26-FST*) cochlear cross sections, stage E14.5. GFP expression (GFP, green) marks hair cells (yellow arrow), SOX2 staining (red) marks the sensory domain. Scale bar 100 µm. (**E**) RT-qPCR-based analysis of gene expression in FST overexpressing (FST) and control cochlear epithelia (Ctrl). Data are mean ± SEM (n = 4--5 animals per group, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, student's t-test). (**F**) Western blot-based analysis of p-SMAD2/3 and p-SMAD1/5/9 protein expression in stage E14.5 *FST* transgenic (FST: 1--4) and control (Ctrl: 1--3) cochlear epithelia. Beta-actin was used as loading control. (**G**) Quantification of p-SMAD2/3 and p-SMAD1/5/9 protein levels in F.](elife-47613-fig3){#fig3}

Consistent with FST antagonizing hair cell differentiation, we found that *Atoh1* and *Pou4f3* mRNA expression was significantly reduced in E14.5 FST overexpressing cochlear epithelia, whereas the mRNA expression of *Id3* and *Id4* was significantly increased compared to control ([Figure 3E](#fig3){ref-type="fig"}). In addition, FST overexpression resulted in a modest but significant increase in the expression of the SHH receptor encoding gene *Ptch1* ([@bib15]) and the FGFR target and effector gene *Etv5* ([@bib19]). Despite these changes, the expression of *Fgf20, Hey1* and *Hey2*, which are targets and effectors of SHH/FGFR signaling ([@bib5]; [@bib53]), remained unchanged in response to FST overexpression ([Figure 3E](#fig3){ref-type="fig"}). Interestingly, FST overexpression also led to a modest but significant reduction in the expression of *Bmp4*. To investigate whether FST overexpression selectively disrupted Activin and/or BMP signaling, we analyzed P-SMAD2/3 and P-SMAD1/5/9 protein levels in cochlear epithelial protein extracts obtained from E14.5 FST overexpressing embryos and their control littermates. Consistent with its role as a canonical Activin antagonist, overexpression of FST significantly reduced P-SMAD2/3 protein levels in the developing cochlea. By contrast, cochlear P-SMAD1/5/9 protein levels, a readout for BMP signaling, remained unchanged in response to FST overexpression ([Figure 3F,G](#fig3){ref-type="fig"}), suggesting that FST overexpression does not disrupt BMP signaling in the developing cochlea.

To address whether Activin A can rescue the FST mediated delay in hair cell differentiation, we harvested cochlear tissue from stage E13.5 FST overexpressing (*R26-FST*) embryos and their single transgenic wild type littermates, cultured them with or without Activin A and monitored hair cell differentiation for the next 48 hr ([Figure 4A](#fig4){ref-type="fig"}). Consistent with our earlier findings, we observed that hair cell differentiation occurred significantly earlier in Activin A-treated wild type cochlear explants compared to untreated wild type cochlear explants ([Figure 4B,C,F](#fig4){ref-type="fig"}). Conversely, the onset of hair cell differentiation was significantly delayed in untreated FST overexpressing cochlear explants compared to untreated wild type cochlear explants ([Figure 4B,D,F](#fig4){ref-type="fig"}). These defects were almost completely abolished when Activin A treatment and FST overexpression were combined and no significant differences in the onset or in the progression of hair cell differentiation was observed between FST overexpressing cochlear explants treated with Activin A and wild type untreated cochlear explants ([Figure 4B,E,F](#fig4){ref-type="fig"}). In summary, our data suggest that FST antagonizes hair cell differentiation in an Activin A-dependent manner.

![Exogenous Activin A rescues the FST induced delay in auditory hair cell differentiation.\
(**A**) Experimental design for B-E. Dox was administered to timed pregnant dams starting at E11.5. At E13.5, cochlear tissue from FST overexpressing embryos (*R26-FST*) and wild type littermates were cultured for 48 hr with or without Activin A (500 ng/ml). (**B--E**) *Atoh1-GFP* reporter expression (GFP, gray) marks nascent hair cells. Asterisks indicate hair cells within vestibular sacculus. Yellow arrows mark nascent cochlear hair cells. Scale bar, 100 μm. (**F**) The length of the GFP positive sensory epithelium was used to quantify the extent of hair cell differentiation in wild type (WT) and FST overexpressing (FST) cochlear explants cultured with and without Activin A. Data expressed as mean ± SEM (n = 5--8 cochlear explants per group, \*p≤0.05, \*\*p\<0.01, \*\*\*p\<0.001, student's t-test). Two independent experiments were conducted and data compiled.](elife-47613-fig4){#fig4}

Disruption of Activin signaling results in ectopic inner hair cell formation {#s2-4}
----------------------------------------------------------------------------

Next, we analyzed whether FST overexpression altered the cellular patterning of the sensory epithelium. Induction of FST overexpression at E11.5 or as late as E14.5 resulted in neonatal lethality of *R26-FST* transgenic animals, limiting our analysis to late embryonic stages. We used native GFP (*Atoh1-GFP*) expression, myosin VII a (Myo7a) immunostaining and phalloidin labeling to identify hair cells and SOX2 immunostaining to identify supporting cells. As expected, cochlear tissue from stage E18.5 control embryos contained a single row of inner hair cells and three rows of outer hair cells ([Figure 5A,B](#fig5){ref-type="fig"}, *Control*). By contrast, *R26-FST* cochlear tissue contained two rows of inner hair cells throughout the basal half of the cochlea ([Figure 5A,B](#fig5){ref-type="fig"}, *R26-FST*). The observed ectopic inner hair cells were unlikely to be the product of supporting cell-to-hair cell fate conversion, as the density of supporting cells that surrounded inner hair cells-called inner phalangeal cells- was similarly increased in response to FST overexpression ([Figure 5C,D](#fig5){ref-type="fig"}). Interestingly, the outer hair cell density and cellular patterning was unchanged in response to FST overexpression except for the cochlear base. The base of FST overexpressing cochleae contained short stretches of sensory epithelium in which the third row of outer hair cells was missing, resulting in a modest reduction in outer hair cell density ([Figure 5B,C](#fig5){ref-type="fig"}). Furthermore, differentiation/maturation of the auditory sensory epithelium was severely delayed in response to FST overexpression. Usually, at stage E18.5, the basal-to-apical wave of differentiation has reached the apex and the initially multilayered auditory sensory epithelium has thinned to a two-layered sensory epithelium, and is near its final length ([@bib16]). Moreover, hair cells throughout the cochlea have formed actin-rich apical protrusions, referred to as stereocilia ([@bib51]) ([Figure 5B](#fig5){ref-type="fig"}, Control). Consistent with a severe delay in hair cell differentiation, auditory sensory epithelia from *R26-FST* transgenic animals had not yet thinned to a single layer of supporting cells ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) and their length was 30% shorter compared to auditory sensory epithelia from control littermates (single transgenic control = 5.14 ± 0.04 mm, *R26-FST* = 3.65 ± 0.13 mm, n = 5, p=0.0002). Moreover, hair cells in FST overexpressing cochlear tissue had less mature stereocilia than their wild type counterparts, and apical hair cells lacked stereocilia completely ([Figure 5B](#fig5){ref-type="fig"}, *R26-FST*).

![FST overexpression in the developing cochlea disrupts inner hair cell patterning and delays hair cell maturation.\
*FST* transgenic (*R26-FST*) embryos and their control (wild type or single transgenic) littermates were exposed to dox starting at E11.5 until tissue harvest at E18.5. (**A**) FST overexpression results in ectopic inner hair cells. Shown are cross-sections through the cochlear mid-base of control and *R26-FST* transgenic embryos. GFP (green) and Myo7a (red) label inner hair cells (IHC, white arrowhead) and outer hair cells (OHC, white bar). Red asterisks mark ectopic inner hair cells. SOX2 (blue) labels supporting cells including inner phalangeal cells (IPH), pillar cells (PC) and Deiters' cells (DC) indicated by white arrows. Scale bar 50 µm. (**B**) FST overexpression delays stereocilia formation. Shown are z-stack projections of the luminal surface of control and *R26-FST* transgenic cochlear sensory epithelia. Phalloidin labels actin-rich stereocilia of inner (white arrowhead) and outer hair cells (white bar). Red asterisks mark ectopic inner hair cells. Yellow arrows mark the location of missing outer hair cells. Scale bar 50 µm. (**C--D**) Quantification of hair cell (**C**) and supporting cell (**D**) density in the base, mid and apex of control (Ctrl, gray bars) and FST overexpressing (FST, purple bars) cochleae. Abbreviations: IHC, inner hair cells; OHC, outer hair cells; IPH, inner phalangeal cells; PC, pillar cells; DC, Deiters' cells; B, base; M, mid; A, apex. Data expressed as mean ± SEM (n = 3 animals per group, \*p≤0.05, \*\*p\<0.01, student's t-test).](elife-47613-fig5){#fig5}

FST induction one day later at \~E13.0 (dox E12.5), had no effect on the length of the auditory sensory epithelium (dox E12.5, harvest E17.5: single transgenic control = 4.13 ± 0.17 mm, *R26-FST* = 3.99 ± 0.12 mm, n = 3, p=0.5425). However, we continued to observe ectopic inner hair cells in FST overexpressing cochleae, with the highest number of ectopic hair cells found in the basal portion of the auditory sensory epithelium, as well as short stretches of sensory epithelium with only two rows of outer hair cells ([Figure 6A,B](#fig6){ref-type="fig"}), indicating that the FST-induced defects in hair cell patterning were not the result of stunted cochlear outgrowth (extension). Furthermore, we found that hair cell stereocilia in FST overexpressing cochleae had a less mature phenotype compared to their counterparts in control cochlear tissue, indicating that FST induction as late as \~E13.0 causes a delay in hair cells differentiation/maturation ([Figure 6A](#fig6){ref-type="fig"}).

![Activin signaling is required for patterning and maturation of hair cells.\
(**A--B**) FST overexpression at E12.5 delays hair cell maturation and causes a mild overproduction of inner hair cells. *FST* transgenic (*R26-FST*) embryos and their control (single transgenic) littermates were exposed to dox starting at E12.5 until tissue harvest at E17.5. (**A**) Shown are the apical surfaces of hair cells located in the base, mid and apex of control and *R26-FST* transgenic cochlear sensory epithelia. Phalloidin labels actin-rich stereocilia of inner (white arrowhead) and outer hair cells (white bar). Red asterisks mark ectopic inner hair cells. White arrows mark location of missing outer hair cells. Scale bar 50 µm. (**B**) Graphed are the number of ectopic inner hair cells (IHC) within the most basal segment (0--0.5 mm) and within the entire length (0--4 mm) of control (Ctrl, gray) and FST overexpressing (FST, purple) cochleae. Data expressed as mean ± SEM (n = 3 animals per group, \*\*\*\*p\<0.0001, student's t-test). (**C-D**) Conditional ablation of the *Inhba* gene delays hair cell maturation and causes a mild overproduction of inner hair cells. (**C**) Shown are the apical surfaces of hair cells located in the base, mid and apex of stage P0* Inhba fl/fl* (control) and *P*ax2*-Cre Inhba fl/fl* (*Inhba* cKO) cochlear sensory epithelia. Phalloidin labels actin-rich stereocilia of inner (white arrowhead) and outer hair cells (white bar). Red asterisks mark ectopic inner hair cells. Scale bar 50 µm. (**D**) Graphed are the number of ectopic inner hair cells (IHC) within the most basal segment (0--0.5 mm) and within the entire length (0--4 mm) of control (Ctrl, gray) and *Inhba* mutant (*Inhba* cKO, orange) cochleae. Data expressed as mean ± SEM (n = 3 animals per group, \*p≤0.05, \*\*\*p\<0.001).](elife-47613-fig6){#fig6}

To determine whether FST influences hair cell differentiation and patterning in an Activin A-dependent manner, we analyzed hair cell morphology and patterning in Activin A (*Inhba*) mutant mice. To selectively ablate *Inhba* gene function in the developing inner ear, we intercrossed *Inhba* floxed mice , in which exon 2 of the *Inhba* gene is flanked by LoxP sites ([@bib44]), with inner ear-specific *Pax2-Cre* transgenic mice (*P*ax2-Cre; *Inhba fl/fl)* ([@bib43]). The conditional knockout (cKO) of the *Inhba* gene did not alter overall cochlear morphology, nor did it alter the length of the sensory epithelium compared to control (*Inhba fl/fl*) (P0: control = 4.99 ± 0.12 mm; *Inhba* cKO = 4. 82 ± 0.01 mm; n = 2, p-value=0.4043).

However, as predicted, loss of *Inhba* gene function resulted in hair cell maturation and patterning defects. The observed defects were much milder, but qualitatively similar to the defects observed in response to FST overexpression (dox E12.5). Cochlear tissue from control littermates (*Inhba fl/fl*) contained the normal complement of one row of inner hair cells and three rows of outer hair cells ([Figure 6C](#fig6){ref-type="fig"}, *Control*). By contrast, *Inhba* cKO cochlear tissue showed a significant increase in the number of ectopic inner hair cells compared to control, with more of the ectopic inner hair cells residing within the most basal segment ([Figure 6C](#fig6){ref-type="fig"}, *Inhba* cKO*, D*). Furthermore, consistent with a delayed onset of hair cell differentiation, hair cell stereocilia in the base, mid and apex of *Inhba* mutant cochlear tissue had a less mature phenotype compared to their counterparts in control cochlear tissue ([Figure 6C](#fig6){ref-type="fig"}). Taken together, our findings demonstrate that *Inhba* (Activin A) function is required for limiting inner hair cell formation as well as for timing hair cell differentiation/maturation in vivo.

The milder defects in cochlear hair cell formation observed in *Inhba* mutants suggest that in addition to Activin A signaling, FST likely disrupts other, Activin-related signaling mechanisms in the developing cochlea. Like Activin A, Activin B (*Inhbb*) and the Activin-related ligands GDF11 and Myostatin (*Mstn*) activate SMAD2/3 signaling and are high affinity binding partners of FST ([@bib54]; [@bib55]). To determine whether *Gdf11*, *Inhbb*, *Mstn* are expressed within the developing cochlear epithelial duct, we conducted a series of RT-qPCR experiments ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We found *Gdf11* transcript to be abundantly expressed at the onset of (E13.5) as well as during (E14.5, E15.5) cochlear differentiation, making it a likely candidate for FST-mediated regulation. By contrast, *Inhbb* and *Mstn* transcripts were undetectable or expressed at very low levels.

Overexpression of FST delays cochlear pro-sensory cell cycle exit {#s2-5}
-----------------------------------------------------------------

The supernumerary inner hair cells and inner phalangeal cells observed in *R26-FST* transgenic animals could have been the product of prolonged proliferation of medially located pro-sensory cells, or they could have been created by a shift in the medial boundary of the pro-sensory domain, leading to the recruitment of non-sensory cells to develop as inner hair cell and inner phalangeal cells ([@bib2]). To distinguish between these two possibilities, we induced FST overexpression at E11.5 and analyzed the spatial and temporal pattern of pro-sensory cell cycle exit in *R26-FST* transgenic animals and their non-transgenic littermates (control). In the murine cochlea, cell cycle exit occurs within a 48 hr time window, with apically located pro-sensory cells exiting the cell cycle as early as E12.5 and pro-sensory cells located in the base of the cochlea exiting as late as E14.5 ([@bib28]; [@bib47]). In our first set of experiments we injected timed pregnant dams with the thymidine analog EdU at stage E13.5, which corresponds with the peak of pro-sensory cell cycle withdrawal and analyzed EdU incorporation in differentiated auditory hair cell and supporting cells five days later (stage E18.5).

Consistent with previous reports, we found that hair cells located in the basal turn of the cochlea incorporated EdU at high rate (\~25%) in both control and *R26-FST* transgenic animals ([Figure 7A--C](#fig7){ref-type="fig"}). However, while control cochlear hair cells located further apically (mid and apex) showed little to no EdU incorporation, their counterparts in FST overexpressing cochleae exhibited robust EdU incorporation ([Figure 7A--C](#fig7){ref-type="fig"}), indicating that FST overexpression in the developing cochlea delays pro-sensory cell cycle withdrawal. FST overexpression did not disrupt the apical-to-basal gradient of pro-sensory cell cycle withdrawal. This was illustrated by the fact that similar to control tissue, inner and outer hair cells located at the apex of FST overexpressing tissue incorporated EdU a significantly lower rate than their counterparts located in the base of the cochlea ([Figure 7A,D,E](#fig7){ref-type="fig"}).

![FST overexpression delays pro-sensory cell cycle exit.\
Timed mated pregnant dames received dox beginning at E11.5, followed by a single injection of EdU at E13.5. At E18.5, *FST* transgenic (*R26-FST*) embryos and their control (wild type or single transgenic) littermates were harvested and analyzed for EdU incorporation (red). (**A**) Shown are cross-sections through the base, mid and apical turn of control and FST overexpressing cochlear tissue. *Atoh1-GFP* transgene expression (GFP, green) marks inner hair cells (IHC, white arrowhead) and outer hair cells (OHC, white bar). SOX2 immunostaining (magenta) marks supporting cells including inner phalangeal cells (IPH), pillar cells (PC) and Deiters' cells (DC) marked by white arrows. Ectopic inner hair cells are marked by red arrowheads. Scale bar, 50 µm. (**B--E**) Graphed are the percentage of EdU positive outer hair cells (OHC) and inner hair cells (IHC) that were observed within the base, mid and apex of control (Ctrl) and FST overexpressing (FST) cochlear whole mounts. Data expressed as mean ± SEM (n = 4 animals per group, \*p≤0.05, \*\*p\<0.01, student's t-test).](elife-47613-fig7){#fig7}

Overexpression of FST abolishes a medial-to-lateral gradient of pro-sensory cell cycle exit {#s2-6}
-------------------------------------------------------------------------------------------

Interestingly, our analysis revealed that in wild type cochlear tissue inner and outer hair cell progenitors did not withdraw from the cell cycle at the same time. We found that in the mid-turn of control cochleae more than 6% of outer hair cells were labeled with EdU, whereas no EdU incorporation was found in inner hair cells, suggesting that inner hair cell progenitors had exited the cell cycle prior to the more laterally located outer hair cell progenitors ([Figure 7D](#fig7){ref-type="fig"}). By contrast, no difference in the frequency of EdU incorporation among inner and outer hair cells was observed in FST overexpressing cochleae ([Figure 7E](#fig7){ref-type="fig"}).

To further characterize the effects of FST on inner hair cell progenitor proliferation, we administered EdU daily from E14.5 until E17.5, and analyzed EdU incorporation in hair cells and supporting cells at E18.5. Again, consistent with a severe delay in pro-sensory cell cycle exit, supporting cells and hair cells in *R26-FST* transgenic animals incorporated EdU at much higher frequency than their counterparts in control (single transgenic) animals ([Figure 8A--D](#fig8){ref-type="fig"}). In control cochlear tissue, consistent with the existence of a medial-to-lateral gradient of cell cycle withdrawal, the percentage of outer hair cells (12.1%) that incorporated EdU was significantly higher compared to the percentage of inner hair cells (1.5%) that incorporated EdU ([Figure 8E](#fig8){ref-type="fig"}). By contrast, in FST overexpressing cochlear tissue, inner hair cells incorporated EdU at a similar or higher rate than outer hair cells ([Figure 8F](#fig8){ref-type="fig"}) and in its apex inner hair cells and their surrounding inner phalangeal cells were the only cell types that were labeled with EdU ([Figure 8A,B,D](#fig8){ref-type="fig"}).

![Overexpression of FST disrupts a medial-lateral gradient of pro-sensory cell cycle exit.\
Timed mated pregnant dam received dox beginning at E11.5, followed by two daily injections of EdU starting at E14.5 until E17.5. At E18.5, *FST* transgenic (*R26-FST*) embryos and their control (single transgenic) littermates were harvested and analyzed for EdU incorporation (red). (**A**) Shown are basal, mid and apical segments of control and FST overexpressing auditory sensory epithelia. Myo7a immuno-staining (green) marks inner (black arrowhead), outer (black bar) and ectopic inner hair cells (red arrow head). SOX2 immuno-staining (blue) marks surrounding supporting cells and less mature hair cells. Scale bar, 50 µm. (**B--C**) FST overexpression (FST, purple bars) significantly increases the percentage of EdU positive inner (IHC) (**B**) and outer hair cells (OHC) (**C**) compared to control (Ctrl, gray bars). (**D**) FST overexpression (FST, purple bars) significantly increases the percentage of EdU positive inner phalangeal cells (IPH), pillar cells (PC) and Deiters cells compared to control (Ctrl, gray bars). (**E**) In control cochlear tissue IHCs (blue) incorporate EdU at a significantly lower rate than OHCs (yellow). (**F**) In FST overexpressing cochlear tissue IHCs (blue) and OHCs (yellow) incorporate EdU at a similar rate. Abbreviations: B, base; M, mid; A, apex. Data expressed as mean ± SEM (n = 3 animals per group \*\*p\<0.01, \*\*\*p\<0.001, student's t-test).](elife-47613-fig8){#fig8}

Taken together, these findings suggest that the ectopic hair cells observed in FST overexpressing cochlear tissue are, at least in part, the product of prolonged proliferation of inner hair cell progenitor cells.

Discussion {#s3}
==========

Signaling gradients play a fundamental role in controlling growth and differentiation during embryonic development. Here, we identify Activin A and its antagonist FST as key regulators of auditory hair cell differentiation. We show that Activin A acts as differentiation signal for sensory hair cells and present evidence that a counter gradient of Activin A and FST times the wave of hair cell differentiation within the developing murine cochlea. Finally, we provide evidence that Activin-type signaling regulates a previously unrecognized radial gradient of pro-sensory cell cycle withdrawal, limiting the number of inner hair cells being produced.

Activin A functions as a pro-differentiation signal in the mammalian cochlea {#s3-1}
----------------------------------------------------------------------------

We find that exogenous Activin A triggers premature hair cell differentiation in cochlear explant cultures and demonstrate that disruption of Activin A signaling due to *FST* overexpression or *Inhba* deletion results in a delay in cochlear hair cell differentiation in vivo. How does Activin signaling promote cochlear hair cell differentiation? The function of Activin signaling in cell proliferation and cell differentiation is highly dependent on cellular context. This has been attributed to the cross-talk and cross-regulation between the Activin signaling pathway and other key developmental pathways ([@bib34]). One possible scenario is that Activin signaling promotes hair cell differentiation through mitigating the hair cell-repressive activity of SHH signaling. For instance, Activin signaling has been shown to promote cortical interneuron differentiation, at least in part, through the inhibition of SHH signaling ([@bib9]). However, we found no evidence for direct interference as neither over-activation nor loss of Activin signaling altered the expression of SHH target and effector genes *Hey1*, *Hey2* and *Fgf20* ([@bib5]; [@bib53]).

Another possible scenario is that Activin-SMAD2/3 signaling directly trans-activates the transcription of *Atoh1.* We did observe a robust increase in *Atoh1* transcript abundance in response to 24 hr Activin treatment. However, a brief 4 hr Activin A treatment failed to significantly increase *Atoh1* transcript abundance, suggesting that Activin signaling does not activate *Atoh1* expression directly but rather through indirect mechanisms. Indeed, our findings suggest that Activin signaling positively regulates ATOH1 activity/expression through inhibiting cochlear expression of *Id3* and *Id4*. Members of the ID family of proteins interfere with the ability of bHLH transcription factors to bind DNA and trans-activate their targets genes ([@bib4]; [@bib56]), which in the case of ATOH1 would render it incapable of upregulating its own transcription and inducing hair cell formation ([@bib6]; [@bib20]). Consistent with an inhibitory role in hair cell differentiation, previous studies found that a failure to downregulate *Id3* expression in hair cell progenitors inhibits the formation of hair cells in both auditory and vestibular sensory organs ([@bib24]; [@bib25]). The role of ID4 in inner ear development has yet to be established.

It should be noted that *Atoh1* expression and subsequent hair cell differentiation is not disrupted, but rather delayed in response to FST overexpression or *Inhba* ablation, suggesting the existence of Activin-independent mechanisms capable of activating *Atoh1* expression in pro-sensory cells. A likely candidate is the Wnt/β-catenin signaling pathway. The Wnt effector β-catenin is required for hair cell specification and has been shown to directly activate *Atoh1* transcription in neuronal progenitors ([@bib49]; [@bib50]). Taking these recent findings and our findings into consideration, we propose a model in which Wnt/β-catenin signaling initiates *Atoh1* expression, whereas Activin signaling functions to enhance *Atoh1* expression/activity along the longitudinal cochlear axis.

What are the signal(s)/factor(s) that set up the distinct pattern of cochlear *Inhba* and *Fst* expression? Early SHH signaling, presumably from the ventral midline, is critical for establishing regional identity in the developing cochlea, including setting up the distinct basal--apical pattern of *Inhba* and *Fst* expression. However, subsequent SHH signaling from the spiral ganglion is dispensable for establishing/maintaining *Inhba* and *Fst* expression ([@bib52]), suggesting the involvement of additional, yet to be identified upstream regulators. A potential candidate for inducing *Inhba* expression at the onset of hair cell differentiation is the Notch signaling pathway. Notch signaling is active in pro-sensory cells and has been shown to positively regulate *Inhba* expression in differentiating and terminal differentiated supporting cells ([@bib10]; [@bib35]).

FST maintains pro-sensory cells in a proliferative and undifferentiated state {#s3-2}
-----------------------------------------------------------------------------

We show that FST overexpression delays the onset of pro-sensory cell cycle withdrawal and differentiation. A similar function in timing pro-sensory cell withdrawal and differentiation has been recently reported for the RNA binding protein LIN28B ([@bib18]). Interestingly, the expression of *Fst* in the developing cochlea largely mimics that of *Lin28b*; each are initially highly expressed in pro-sensory cells and are downregulated upon differentiation following a basal-to-apical gradient. Regulatory and functional connections between Activin signaling and LIN28B have not yet been established and it will be of interest to determine whether a link between LIN28B and FST exists.

TGF-β-related signaling pathways are known to inhibit proliferation through promoting the expression and/or activity of cyclin dependent kinase (CDK) inhibitors ([@bib37]). In the developing cochlea, the CDK inhibitor p27/Kip1 (CDKN1B) is the main regulator of pro-sensory cell cycle exit and its transcriptional upregulation directs the apical-to-basal wave of pro-sensory cell cycle withdrawal ([@bib12]; [@bib28]). However, we observed no changes in p27/Kip1 mRNA expression in response to FST overexpression, suggesting that the observed delay in pro-sensory cell cycle exit may instead be due to a reduction in p27/Kip1 protein stability and/or activity. In addition, it is likely that the increase in *Id3* and *Id4* expression in response to FST overexpression contributed to the observed delay in pro-sensory cell cycle exit. High ID protein expression is associated with a proliferative, undifferentiated cell state and ID4 expression in spermatogonia and mammary glands is a predictor for stemness ([@bib21]; [@bib56]). Does FST target other Activin-type ligands in the developing cochlea? This is quite likely as *Fst* can be detected within the most ventral aspect of the developing otocyst as early as E10.5, preceding Activin A expression by several days ([@bib51]). Furthermore, the cochlear defects observed in *Inhba* mutants are much milder compared to the cochlear defects observed in *FST* transgenic animals. A potential candidate is GDF11, which our qPCR-based expression analysis identified as the predominant Activin-type ligand within the developing cochlea. GDF11--FST axis has been shown to regulate progenitor cell proliferation and differentiation in various sensory tissues ([@bib3]; [@bib17]; [@bib26]). However, the role of GDF11 in the developing cochlea has not yet been addressed and future investigations are warranted.

Interestingly, the negative role of Activin-type signaling in cochlear cell proliferation appears to be not conserved between mammalian and avian species. In adult chicken auditory sensory epithelia disruption of Activin signaling attenuates the low rate of regenerative cell proliferation, whereas exogenous Activin A stimulates cell proliferation ([@bib38]).

A radial Activin-FST counter gradient controls the production of inner hair cells {#s3-3}
---------------------------------------------------------------------------------

We find that FST overexpression and to a lesser extent ablation of Activin A (*Inhba*) results in an overproduction of inner hair cells. In certain tissues, including the developing tongue, FST has been shown to interfere with BMP signaling ([@bib3]). In the mammalian cochlea BMP-receptor signaling is critical for the specification of sensory and non-sensory territories and the medial-lateral partitioning of the pro-sensory domain ([@bib42]) ([@bib40]; [@bib45]). Thus, it could be reasoned that the observed increase in inner hair cells in FST overexpressing cochleae is the result of defects in medial-lateral patterning caused by the loss of BMP signaling. However, we found no evidence that FST overexpression disrupted or significantly reduced BMP signaling within the developing cochlea. FST overexpression did not reduce protein levels of the BMP effectors p-SMAD1/5/9, nor did it reduce the expression of BMP target genes *Id1-3*.

Instead, we propose that the ectopic inner hair cells in *FST* transgenic and *Inhba* mutant animals are the product of prolonged inner hair cell progenitor proliferation. We show that under normal conditions inner hair cell progenitors withdraw from the cell cycle prior to outer hair cell progenitor cells. Moreover, we demonstrate that this distinct medial-to-lateral gradient of terminal mitosis is lost in FST overexpressing cochlear tissue, resulting in a disproportional increase in inner hair cells. What informs the radial gradient of terminal mitosis in wild type cochlear tissue? We show that at the peak of terminal mitosis (E13.5), *Fst* expression becomes restricted to the lateral portion of the pro-sensory domain, suggesting that inner hair cell progenitors experience higher levels of Activin-type signaling (Activin A, GDF11) than more laterally located outer hair cell progenitor cells. This newly identified radial gradient of terminal mitosis constitutes a novel mechanism for limiting the number of inner hair cells that are being produced in the mammalian cochlea.

Materials and methods {#s4}
=====================

Experimental animals {#s4-1}
--------------------

*Atoh1-GFP* transgenic mice (RRID:[MGI:3703598](https://scicrunch.org/resolver/MGI:3703598), Tg(Atoh1-GFP)1Jejo ([@bib33]) were obtained from Jane Johnson, University of Texas, Southwestern Medical Center. *Pax2-Cre* BAC transgenic mice (RRID:[MGI:3046196](https://scicrunch.org/resolver/MGI:3046196), Tg(Pax2-cre)1Akg) ([@bib43]) were obtained from Andrew Groves, Baylor College. *Inhba floxed* mice (RRID: [MGI:3758877](https://scicrunch.org/resolver/MGI:3758877), Inhba^tm3Zuk^) ([@bib44]) were obtained from Martin Matzuk, Baylor College. The *R26-M2rtTA* mice (RRID:[MGI:3798943](https://scicrunch.org/resolver/MGI:3798943), B6.Cg-Gt(ROSA)26Sortm1(rtTA\*M2)Jae/J) ([@bib22]) were purchased from Jackson Laboratories (Bar Harbor, ME, no. 006965). *FST* transgenic mice were obtained from Se-Jin Lee, Johns Hopkins University School of Medicine. In this line a cassette encoding the human FST-288 isoform is under the control of a tetracycline-responsive promoter element (tetO) ([@bib29]; [@bib46]). Mice were genotyped by PCR using the listed primers. *[Pax2-Cre]{.ul}*: Cre1F (GCC TGC ATT ACC GGT CGA TGC AAC GA), Cre1R (GTG GCA GAT GGC GCG GCA ACA CCA TT) yields a 700 bp band. *[Inhba floxed]{.ul}*: Inhba fx1 (AAG AGA GAA TGG TGT ACC TTC ATT), Inhba fx2 (TAT AAC CTG GGT AAG TGG GT), Inhba fx3 (AGA CGT GCT ACT TCC ATT TG) yield a 400 bp band for the floxed allele and a 280 bp for the wild type allele. *[R26-M2rtTA]{.ul}*: MTR (GCG AAG AGT TTG TCC TCA ACC), F (AAA GTC GCT CTG AGT TGT TAT), WTR (GGA GCG GGA GAA ATG GAT ATG) yield a 340 bp band for the mutant allele and a 650 bp for the wild type allele. *[FST]{.ul}:* YA88 (TTG CCT CCT GCT GCT GCT GC), YA123 (TTT TTC CCA GGT CCA CAG TCC ACG) yields a 247 bp band for the *FST* transgene. *[Atoh1-GFP]{.ul}*: EGFP1 (CGA AGG CTA CGT CCA GGA GCG CAC), EGFP2 (GCA CGG GGC CGT CGC CGA TGG GGG TGT) yields a 300 bp band for GFP. Mice were maintained on a C57BL/6; CD-1 mixed background. Mice of both sexes were used in this study. Embryonic development was considered as E0.5 on the day a mating plug was observed. To induce *FST* transgene expression doxycycline (dox) was delivered to time-mated females via ad libitum access to feed containing 2 grams of dox per kilogram feed (Bioserv, no. F2893). All experiments and procedures were approved by the Johns Hopkins University Institutional Animal Care and Use Committee (protocol \#MO17M318), and all experiments and procedures adhered to the National Institutes of Health-approved standards.

Tissue harvest and processing {#s4-2}
-----------------------------

Embryos and early postnatal pups were staged using the EMAP eMouse Atlas Project (<http://www.emouseatalas.org>) Theiler staging criteria. Inner ear cochleae were collected in HBSS (Corning, no. 21--023-CV). To free the cochlear epithelial duct from surrounding tissue, dispase II (1 mg/ml; Gibco, no. 17105041) and collagenase (1 mg/ml; Worthington, no. LS004214) mediated digest was used as previously described ([@bib18]). To obtain cochlear whole mount preparations (also referred to as surface preparations), the cochlear capsule, spiral ganglion, and Reissner's membrane were removed, and the remaining tissue was fixed overnight in 4% (vol/vol) paraformaldehyde (PFA) (Electron Microscopy Sciences, no. 15714) in PBS. To obtain cochlear sections, heads were fixed in 4% PFA in PBS, cryoprotected using 30% sucrose in PBS, and embedded in Tissue-Tek O.C.T. Compound (Sakura Finetek). Tissue was sectioned at a thickness of 14 µm and collected on SuperFrost Plus slides (Thermo Scientific, no. 12-550-15) and stored at −80°C.

Histochemistry and in situ hybridization {#s4-3}
----------------------------------------

Immunostaining was performed according to the manufacturer's specifications. Primary antibodies: rabbit anti-myosinVIIa (1:500; Proteus, no. 25--6790, RRID: [AB_10015251](https://scicrunch.org/resolver/AB_10015251)), rabbit anti SOX2 (1:500; Millipore, no. AB5603, RRID:[AB_2286686](https://scicrunch.org/resolver/AB_2286686)) goat anti-SOX2 (1:500; Santa Cruz, no. sc-17320, RRID: [AB_2286684](https://scicrunch.org/resolver/AB_2286684)), rabbit anti-PROX1 (1:500; Covance, no. PRB-238C, RRID: [AB_291595](https://scicrunch.org/resolver/AB_291595)). Cell nuclei were fluorescently labeled with Hoechst-33258 solution (Sigma, no. 94403). Actin filaments were labeled with Alexa Fluor 488 phalloidin (1:1000; Invitrogen, no. A12379) or Alexa Fluor 546 phalloidin (1:1000; Invitrogen, no. A22283). Secondary antibodies: anti-rabbit and anti-goat IgG (H + L) Alexa Fluor (488, 546 and 647) labeled secondary antibodies (1:1000; Invitrogen) and biotinylated donkey anti-goat IgG (H + L) (1: 500; Jackson Immuno Research laboratories, no. 705-065-147) with streptavidin, Alexa Fluor 405 (1:100; Invitrogen, no. S32351) were used for immunostaining. For in situ hybridization digoxigenin (DIG)-labeled antisense RNA probes were prepared according to the manufacturer's specifications (Roche). PCR amplified fragments of *Inhba* (NM_008380, 47--472) and *Fst* (NM_008046, 180--492) were used as template and gene-specific T7 RNA polymerase promoter hybrid primers were used for in vitro transcription. *Atoh1* (NM_007500) and *Sox2* (NM_011443) probes were prepared as previously described ([@bib18]). Probes were detected with the sheep-anti--DIG-alkaline phosphatase (AP) conjugated antibody (1:000; Roche, no. 11093274910) and the color reactions were developed by using BM Purple AP Substrate (Roche, no. 11442074001).

Recombinant protein {#s4-4}
-------------------

Recombinant human/mouse/rat Activin A (R&D Systems, no. 338-AC) was reconstituted in sterile PBS containing 0.1% BSA at a concentration of 50 µg/ml and used at final concentration of 200--500 ng/ml. Recombinant human BMP4 (R&D Systems, no. 314 BP-010) was reconstituted in sterile 4 mM HCl 0.1% BSA at a concentration of 100 µg/ml and used at 100 ng/ml final concentration. Stock solutions were stored at −20°C.

Cochlear explant culture and hair cell differentiation assay {#s4-5}
------------------------------------------------------------

Wild type or FST overexpressing embryos and their control littermates were screened for native GFP expression and staged (see tissue harvest and processing). Embryos of inappropriate stage and GFP negative embryos were discarded. Cochleae from individual embryos were harvested in HBSS (Corning, no. 21--023-CV), and treated with dispase and collagenase to remove the cochlear capsule (see tissue harvest and processing). The remaining tissue, including the cochlear epithelial duct, the vestibular sacculus, and the innervating spiral ganglion, was placed onto SPI-Pore membrane filters (Structure Probe, no. E1013-MB) and cultured in DMEM-F12 (Corning, no. 10--092-CV), 1% Fetal Bovine Serum (FBS) (Atlanta Biologicals), 5 ng/ml EGF (Sigma, no. SRP3196), 100 U/ml penicillin-streptomycin (Sigma, no. P4333), and 1x B-27 Supplement (Gibco, no. 17504044). Activin A (final conc. 500 ng/ml) was added at plating and was replenished daily. All cultures were maintained in a 5% CO~2~/20% O~2~ humidified incubator. To monitor hair cell differentiation, green fluorescent images of native GFP expression were captured using fluorescent stereo-microscopy (Leica, Microsystems). Fluorescent images were analyzed in Photoshop CS6 (Adobe), and the basal-to-apical extent of cochlear GFP expression was measured using ImageJ software (National Institutes of Health).

RNA extraction and RT q-PCR {#s4-6}
---------------------------

Cochlear epithelia were isolated from cultured cochlear explants or freshly harvested inner ear tissue using dispase/collagenase treatment. RNeasy Micro kit (Qiagen, no.74004) was used to isolate total RNA, and mRNA was reverse transcribed into cDNA using iScript kit (Bio-Rad, no. 1708890). Q-PCR was performed with Fast SYBR Green Master Mix reagent (Applied Biosystems, no. 4385614) and gene-specific primer sets on a CFX-Connect Real Time PCR Detection System (Bio-Rad). Each PCR was performed in triplicate. Relative gene expression was analyzed by using the ΔΔCT method ([@bib48]). The ribosomal gene *Rpl19* was used as endogenous reference gene. The following q-PCR primers were used:

GeneForward PrimerReverse Primer*Atoh1*GGCAACAGCTCCCTGAAAACTCCCGCGCGCTAGGAA*Bmp4*ACGTAGTCCCAAGCATCACCACTAGGGTCTGCACAATGGC*Etv5*GAGCCGCTCTCTCCGCTATTCGTTCCCCAGCCACCTT*FST* (h)TTGCCTCCTGCTGCTGCTGCCTCCTTGCTCAGTTCGGTCTTG*Fst* (m)GCTCTTCTGGCGTGCTTCAATGGAAGAGATAGGAAAGCTGT*Fgf20*CACGGGTCGCAGGTATTTTGCCTGGCACCATCTCTTGGA*Gdf11*GCGTCACATCCGTATCCGTTTCCATGAAAGGATGCAGCCCC*Hey1*CACTGCAGGAGGGAAAGGTTATCCCCAAACTCCGATAGTCCAT*Hey2*AAGCGCCCTTGTGAGGAAATCGCTCCCCACGTCGAT*Id1*GAACGTCCTGCTCTACGACATGTGGGCACCAGCTCCTTGA*Id2*AAGGTGACCAAGATGGAAATCCTCGATCTGCAGGTCCAAGATGT*Id3GAGCTCACTCCGGAACTTGTG*CGGGTCAGTGGCAAAAGC*Id4*TGCGATATGAACGACTGCTACATTGTTGGGCGGGATGGTA*Inha*GCTCCTTTTGCTGTTGACCCGTGGCACCTGTAGCTGGGAA*Inhba*GGGTAAAGTGGGGGAGAACGACTTCTGCACGCTCCACTAC*Inhbb*GCGTCTCCGAGATCATCAGCCACCTTGACCCGTACCTTCC*Lgr5*TGAGCGGGACCTTGAAGATTTAATAGGTGCTCACAGGGCTT*Mstn*TCTTGCTGTAACCTTCCCAGGTCGCAGTCAAGCCCAAAGTCP27(*Cdkn1b*)GCAGGAGAGCCAGGATGTCACCTGGACACTGCTCCGCTAA*Pou4f3*GCACCATCTGCAGGTTCGACCGGCTTGAGAGCGATCAT*Ptch1*CTGGCTCTGATGACCGTTGAGCACTCAGCTTGATCCCAATG*Rpl19*GGTCTGGTTGGATCCCAATGCCCGGGAATGGACAGTCA

Western blot {#s4-7}
------------

Individual cochlear epithelia were lyzed in RIPA lysis buffer (Sigma, no. R0278) supplemented with Roche Protease Inhibitor (Sigma, no. 11697498001) and Phosphatase Inhibitor Cocktail no.2 (Sigma, no. P5726) and no.3 (Sigma, no. P0044). Following manufacture recommendations, equal amounts of cochlear protein extract were resolved on NuPAGE 4--12% Bis-Tris Gels (Invitrogen, no. NP0322BOX) and transferred to Immun-Blot PVDF membrane (Bio-Rad) by electrophoresis. Membranes were blocked in 5% no-fat dry milk in TBST and immunoblotted with rabbit anti-P-Smad2/3 (1:1000; Cell Signaling, no.8828 RRID: [AB_2631089](https://scicrunch.org/resolver/AB_2631089)), P-Smad1/5/9 (1:1000; Cell Signaling, no.13820, RRID: [AB_2493181](https://scicrunch.org/resolver/AB_2493181)) and mouse anti-β-actin (1:1000; Santa Cruz, no. SC-47778, RRID: [AB_626632](https://scicrunch.org/resolver/AB_626632)). HRP-conjugated secondary antibodies from Jackson Immuno Research were used at a concentration of 1:10,000 (goat anti-rabbit IgG, no. 111-035-003; sheep anti-mouse IgG no. 515-035-003). Signal was revealed using a Western Lightening Plus ECL kit (Perkin Elmer, no. NEL120E001EA) or SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific, no. 34096) according to manufacturer's instructions.

Quantification of hair cells and supporting cells {#s4-8}
-------------------------------------------------

Cell counts were performed in cochlear whole mounts. Hair cells were identified by their native GFP (*Atoh1-GFP*) expression, as well as by immuno-staining for the hair cell-specific protein myosinVIIa (Myo7a); supporting cells were identified by SOX2 immuno-staining. Classification of cell subtypes was based on their location within the sensory epithelium. Low-power confocal and epi-fluorescent images (ZEISS, Microscopy) of the hair cell layer were used to reconstruct the entire cochlear sensory epithelium. The resulting composite images were used to count ectopic inner hair cells, measure the total length of the sensory epithelia and used to define basal, mid and apical segments (\~1400 µm). For hair cell and supporting cell counts a series of high-power confocal (ZEISS, Microscopy) z-stack images spanning the hair cell and supporting cell layer were taken within the basal, mid and apical segments. The apical tip (\~300--500 µm) was excluded from the analysis. Images were assembled, viewed and analyzed in Photoshop CS6 (Adobe) and LSM image viewer software (ZEISS, Microscopy). Image J (National Institutes of Health) and FIJI software were used to measure the length of counted segments and total length of the sensory epithelium. The FIJI cell counter plugin was used to count cells.

Proliferation assay {#s4-9}
-------------------

EdU (5-ethynyl-2'-deoxyuridine, Invitrogen no. E10187) was reconstituted in PBS and administered at 50 µg per gram of body weight to time-mated pregnant dams per intraperitoneal injection. Click-iT AlexaFluor-488 or -594 Kit (Invitrogen, no. C10337 and no. C10339) was used to detect incorporated EdU according to the manufacturer's specifications. To quantify the number and percentage of EdU positive hair cells and supporting cells, EdU stained cochlear surface preparations were immuno-stained for SOX2 and Myo7a. Length measurements and cell counts were conducted as described above.

Statistical reporting {#s4-10}
---------------------

Values are presented as mean ± standard error of the mean (SEM). The sample size (n) represents the number of biological independent samples (biological replicates) analyzed per experimental group. Two-tailed unpaired Student's t-tests were used to determine the confidence interval, p-values≤0.05 were considered significant. p-values\>0.05 were considered not significant. Biologically independent samples (biological replicates) were allocated into experimental groups based on genotype and/or type of treatment. A minimum of three biological independent samples were analyzed per group. To avoid bias masking was used during data analysis.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for choosing to send your work entitled \"Activin signaling informs the graded pattern of terminal mitosis and hair cell differentiation in the mammalian cochlea\" for consideration at *eLife*. Your initial submission has been assessed by a Senior Editor in consultation with a member of the Board of Reviewing Editors. Although the work is of interest, we are not convinced that the findings presented have the potential significance that we require for publication in *eLife*.

Specifically, while the reviewers agreed that the results are potentially significant, they felt that many modifications and new experiments would be required to bring the paper to a standard that would be acceptable for *eLife*. We refer you to their specific reviews below. Important considerations include discussion of other pathways that may regulate timing of proliferation and differentiation in the cochlea, better citing of the existing literature and further experimentation. In particular, the reviewers were sceptical about some of the crucial interpretations, and felt these needed to be supported by stronger experimental results. If you feel you can address these issues in a future publication, we would be open to considering a significantly revised paper as a new submission for which every effort would be made to return the paper to the same reviewers.

*Reviewer \#1:*

This is an interesting and thorough study that presents new data illustrating a role for Activin/Follistatin signaling in the timing of hair cell differentiation and cellular proliferation within the cochlea. The data are nicely presented and the overall conclusions, that counter gradients of Activin A and Follistatin regulate the timing of hair cell differentiation along the cochlear axis are well supported. My largest concern with the study is that while discussing three other signaling pathways, Shh, FGF and Wnt, that have been shown to also play roles in regulating hair cell differentiation, meaningful data exploring the links between Activin A/Follistatin and any of these other pathways is not presented. Some possibilities are broached in the Discussion section, but no specific interactions are examined. In particular, additional exploration of the link between the Shh/*Fgf20* pathway, which the authors showed to be important for the gradient of hair cell differentiation in a previous study and Activin A/Follistatin, would greatly strengthen this work.

*Reviewer \#2:*

The paper by Prajapati-DiNubila et al., reports the important observation that Activin A and follistatin play a role in the timing of onset of differentiation of the sensory hair cells in the developing organ of Corti. This question; \"What is responsible for timing the onset and progression of HC differentiation along the basal-to-apical gradient?\" is an extremely important one, and the identification of a role for Activin in this process may answer this long-standing issue. The paper clearly shows the effects of Activin and follistatin, but there are a fairly large number procedural and control issues to be dealt with, as well as questions about interpretation.

Using in situ hybridization, in Figure 1, the authors first replicate the observation that Activin A follows a basal-to-apical gradient of expression within the sensory domain of the organ that parallels the timing of hair cell differentiation (Figure 1). They also report a medial-lateral gradient of Activin A and follistatin, that they claim to observe by in situ hybridization, but this is harder to discern in the data as presented (see comment below).

Using an ex vivo culture system that allows hair cell differentiation to proceed from base-to-apex starting at a time just before the appearance of Atoh1, a crucial regulator of hair cell differentiation, the authors show that incubation of the cultures with Activin A leads to a precocious differentiation process, as measured by the basal-to-apical extent of transgenic GFP, reporting Atoh1 protein level, in differentiating hair cells (Figure 2A-G).

Interestingly, but perhaps inconsistent with the authors claim that Activin A regulates Atoh1 directly, they observe that once initiated, the process (rate) of differentiation along the basal-to-apical axis is the same as in the untreated cultures, and patterning is unaffected. Since the whole organ is bathed in exogenous Activin A at the beginning of the experiment, one might expect that Atoh1 would be up-regulated in the apex, as well as the base, however this does not seem to occur. Also, that Activin might stimulate Atoh1 in nascent supporting cells inducing transdifferentiation, which also does not seem to occur. This suggests that it is unlikely that Activin A is regulating Atoh1 directly, and that the modest Atoh1 increase shown by qPCR may represent the change in timing of the initiation of the wave of differentiation.

The Activin A effect on Atoh1 up-regulation is shown to be specific by comparison to BMP4, by qPCR (Figure 2K), though the effect is rather small. Here the data are confounded by use of a different experimental approach, in which a different dissection eliminated surrounding tissue. (subsection "Activin signaling positively regulates Atoh1 gene expression" and Figure 2K) \"We shortened the time of Activin A treatment to 3.5-hours, as well as cultured cochlear epithelia without its surrounding tissue.\" This requires some explanation. What is meant by \"surrounding tissue\" and was this included in the previous qPCR experiment (Figure 2I), or not? It seems that these details of the culture conditions could influence the outcome of the experiment, and so defining them precisely is important.

Activin activity is known to be opposed by follistatin, and in Figure 3, the authors make the case that follistatin limits the differentiation of hair cells. Overexpression of follistatin inhibits the normal basal-to-apical progression of HC differentiation that occurs between E13.5 and E17.5. Together these results suggest a role for ActivinA in timing this progression and a reliance on Folistatin to oppose this process, though why both need to be regulated is not clear. At the gene expression level, it is unclear from the figure whether the change claimed for Atoh1 or Id4 is statistically significant Figure 3F, though the change in phosphor-Smad2/3 in response to follistatin seem to be (Figure 3E). However, the data in Figure 3E needs to be quantified, and the total SMAD 2/3 protein levels shown using a non-phospho-specific antibody. The ability of follistatin overexpression to antagonize the effect of Activin A is shown in Figure 3H-T. Here it would be helpful to better define the \"hair cell domain\" measurement used.

Interestingly, the authors show that Follistatin overexpression appears to delay cell cycle exit in an apical-to-basal direction. And also, claim to show a normal medial-to-lateral gradient of cell cycle exit that is also opposed by follistatin overexpression. However, the data presented in Figure 4I is very difficult to understand, perhaps because of the way it is graphed. It might be useful for the authors to show these data from IHCs and OHCs on two separate graphs (with associated statistics). Nonetheless, the numbers seem to indicate that follistatin increases the percentage of OHCs that take up EdU in the mid-cochlea relative to IHC, suggesting differential sensitivity from medial-to-lateral.

However, this result appears to contrast with the result in the earlier part of Figure 4, which shows the ectopic proliferation in the IHC region to be more robust? Whereas, in Figure 5, where there appears to be an increase in ectopic inner HCs, accompanied by either normal or depleted three rows of outer hair cells in FST-OE. I would have expected, based on Figure 4K, that the opposite might be true

Finally, in Figure 5, the authors use an Inhba knockout strategy, and discover that there are sporadic ectopic inner HCs present in the KO, with an increase from base-to-apex. However, given the increase in proliferation seen in the follistatin OE, one might expect both IHC and OHC to be affected, and that the effect would be stronger and less organized than that shown in Figure 5Q-S. The phenotype shown, that of ectopic IHC occurring in a single row, seems to indicate a problem with border formation, rather than an overproliferation phenotype?

*Reviewer \#3:*

The manuscript \"Acitivin signaling informs the graded pattern of terminal mitosis and hair cell differentiation in the mammalian cochlea\" by Prajapati-DiNublia et al., examines the role of Activin A in hair cell differentiation. Specifically, using cochlear explant cultures as well as genetic mouse models the authors provide evidence that Acivin A is a positive regulator of hair cell differentiation along the basal-to-apical axis of the cochlear duct. Further evidence is provided for a role of Acivin A signaling in terminal mitosis along the medial-to-lateral axis of the cochlear sensory epithelium.

Essential revisions:

In McCullar et al., 2010, the study demonstrated that the addition of Activin A to post-hatch avian auditory sensory epithelium increases proliferation while inhibiting the Activin receptors Acvr2a and 2b results in a decrease in proliferation in the sensory epithelium. This significantly lessens the novelty/impact/advance of the current study. It is unfortunate that the authors did not reference this paper.

Furthermore, in the 2010 study McCullar et al., also demonstrated the expression patterns of the Activin receptors Acvr2a and 2b as well as the downstream Smad effector proteins pSmad2 and pSmad1/5/8 in the mammalian cochlea and vestibule (Figure 11, Figure 12, Figure 13 and Figure 14 and Table 4).

The expression patterns presented in Figure 1 have been previously published as well. Specifically, the expression of Inhba and Fst have been published by Son et al., 2015 at E13.5 (Figure S5), E15.5 (Figure 5) and E18.5 (Figure S6) clearly demonstrating the spatiotemporal basal-to-apical expression of these two molecules. The Atoh1 and *Sox2* expression patterns have also been previously published by many groups including the current authors. Thus, Figure 1 does not offer any significant new information.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Counter gradients of Activin A and follistatin instruct the timing of hair cell differentiation in the mammalian cochlea\" for further consideration at *eLife*. Your revised article has been favourably evaluated by Marianne Bronner (Senior Editor), Tanya Whitfield (Reviewing Editor), and two reviewers.

The authors have done a very nice job of addressing the reviewers\' comments. There are a few remaining suggestions from the reviewers. The further experimental work suggested by reviewer 1 is left to the authors\' discretion. The minor comments from reviewer 2 should be addressed by toning down the interpretations or conclusions in the manuscript.

*Reviewer \#1:*

This is a re-submission by Prajapati-DiNublia et al., examining the role of Activin A in hair cell differentiation.

Initial review:

The expression patterns presented in Figure 1 have been previously published as well. \[...\] Thus, Figure 1 does not offer any significant new information.

Authors\' response:

The purpose of Figure1 is to characterize Atoh1, Inhba and Fst expression at the onset of hair cell differentiation, which the aforementioned study did not provide.

Second review:

I still fail to see what is new in Figure 1. I do appreciate it as an introductory figure.

Initial review:

In Figure 5, it would be best to have low magnification images as well to show the entire cochlea from control and mutant mice in addition to the high mag images. Are the lengths of the cochleae different -- measurements? Are the extra hair cells functional? Are they innervated?

Authors response:

We quantified the length of Inhba mutant and control cochlear tissue and found no difference; the quantitative data are included in the result section. The question whether these extra hair cells are functional is interesting but beyond the scope of our current study.

Second review:

I was not suggesting electrophysiological experiments which I agree would be beyond the scope of this study; rather FM1-43 uptake which would provide evidence of channel/stereociliary function. Furthermore, performing immunohistochemistry to demonstrate innervation phenotypes (if any) is straight forward and would add value to the study.

Lastly, I do agree with the other reviewer that quantification of P-SMAD should include controls showing total receptor protein using antibodies against the un-phosphorylated SMAD form. This would control for changes in total protein levels.

10.7554/eLife.47613.015

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> Specifically, while the reviewers agreed that the results are potentially significant, they felt that many modifications and new experiments would be required to bring the paper to a standard that would be acceptable for eLife. \[...\] If you feel you can address these issues in a future publication, we would be open to considering a significantly revised paper as a new submission for which every effort would be made to return the paper to the same reviewers.
>
> Reviewer \#1:
>
> \[...\] My largest concern with the study is that while discussing three other signaling pathways, Shh, FGF and Wnt, that have been shown to also play roles in regulating hair cell differentiation, meaningful data exploring the links between Activin A/Follistatin and any of these other pathways is not presented. Some possibilities are broached in the Discussion section, but no specific interactions are examined. In particular, additional exploration of the link between the Shh/Fgf20 pathway, which the authors showed to be important for the gradient of hair cell differentiation in a previous study and Activin A/Follistatin, would greatly strengthen this work.

Additional experiments were conducted to analyze whether Activin A and FST influences Shh/*Fgf20* pathway. Our analysis revealed that Activin A treatment or FST overexpression had no significant effect on the expression of transcriptional targets of SHH/*Fgf20* pathway (Hey1, Hey2 and *Fgf20*), suggesting that there is no direct link between SHH signaling and Activin signaling.

> Reviewer \#2:
>
> \[...\] Using an ex vivo culture system that allows hair cell differentiation to proceed from base-to-apex starting at a time just before the appearance of Atoh1, a crucial regulator of hair cell differentiation, the authors show that incubation of the cultures with Activin A leads to a precocious differentiation process, as measured by the basal-to-apical extent of transgenic GFP, reporting Atoh1 protein level, in differentiating hair cells (Figure 2A-G). \[...\] Also, that Activin might stimulate Atoh1 in nascent supporting cells inducing transdifferentiation, which also does not seem to occur.

The preservation of the basal-to-apical gradient is consistent with our observation that the expression of key regulatory genes controlled by SHH signaling are unchanged in response to Activin A treatment, indicating that Activin signaling does not interfere with SHH signaling, which has been shown to be sufficient to maintain apical progenitors undifferentiated.

> This suggests that it is unlikely that Activin A is regulating Atoh1 directly, and that the modest Atoh1 increase shown by qPCR may represent the change in timing of the initiation of the wave of differentiation.

We agree with the reviewer that our current data are most consistent with Activin signaling promoting Atoh1 expression through an indirect mechanism.

> The Activin A effect on Atoh1 up-regulation is shown to be specific by comparison to BMP4, by qPCR (Figure 2K), though the effect is rather small. Here the data are confounded by use of a different experimental approach, in which a different dissection eliminated surrounding tissue. (subsection "Activin signaling positively regulates Atoh1 gene expression" and Figure 2K) \"We shortened the time of Activin A treatment to 3.5-hours, as well as cultured cochlear epithelia without its surrounding tissue.\" This requires some explanation. What is meant by \"surrounding tissue\" and was this included in the previous qPCR experiment (Figure 2I), or not? It seems that these details of the culture conditions could influence the outcome of the experiment, and so defining them precisely is important.

We rewrote the section that describes the experimental approach and now state that enzymatically purified cochlear epithelia were cultured.

> Activin activity is known to be opposed by follistatin, and in Figure 3, the authors make the case that follistatin limits the differentiation of hair cells. Overexpression of follistatin inhibits the normal basal-to-apical progression of HC differentiation that occurs between E13.5 and E17.5. Together these results suggest a role for ActivinA in timing this progression and a reliance on Folistatin to oppose this process, though why both need to be regulated is not clear.

The utility of having both a source (Activin A) and a sink (follistatin) in signaling gradients is well documented (e.g. wnt and wnt antagonists in rostral-caudal patterning of the neural plate).

> At the gene expression level, it is unclear from the figure whether the change claimed for Atoh1 or Id4 is statistically significant Figure 3F, though the change in phosphor-Smad2/3 in response to follistatin seem to be (Figure 3E). However, the data in Figure 3E needs to be quantified, and the total SMAD 2/3 protein levels shown using a non-phospho-specific antibody. The ability of follistatin overexpression to antagonize the effect of Activin A is shown in Figure 3H-T. Here it would be helpful to better define the \"hair cell domain\" measurement used.

We now include detailed information about how the hair cell domain measurements were conducted in the Materials and methods section. We also conducted a new set of experiments (increased number of biological replicates), which revealed significant changes in Atoh1 and Id4 expression in response to FST overexpression (Figure 3 E). We added a quantification of normalized p-Smad2/3 levels.

> Interestingly, the authors show that Follistatin overexpression appears to delay cell cycle exit in an apical-to-basal direction. And also, claim to show a normal medial-to-lateral gradient of cell cycle exit that is also opposed by follistatin overexpression. However, the data presented in Figure 4I is very difficult to understand, perhaps because of the way it is graphed. It might be useful for the authors to show these data from IHCs and OHCs on two separate graphs (with associated statistics). Nonetheless, the numbers seem to indicate that follistatin increases the percentage of OHCs that take up EdU in the mid-cochlea relative to IHC, suggesting differential sensitivity from medial-to-lateral.

As requested, in the revised manuscript OHC and IHC EdU incorporation is now graphed separately. We are puzzled by the reviewer's conclusion that follistatin overexpression increases the percentage of OHCs that take up EdU in the midcochlea compared to IHCs, as this is not what our data indicates.

> However, this result appears to contrast with the result in the earlier part of Figure 4, which shows the ectopic proliferation in the IHC region to be more robust? Whereas, in Figure 5, where there appears to be an increase in ectopic inner HCs, accompanied by either normal or depleted three rows of outer hair cells in FST-OE. I would have expected, based on Figure 4K, that the opposite might be true

See comment above.

> Finally, in Figure 5, the authors use an Inhba knockout strategy, and discover that there are sporadic ectopic inner HCs present in the KO, with an increase from base-to-apex. However, given the increase in proliferation seen in the follistatin OE, one might expect both IHC and OHC to be affected, and that the effect would be stronger and less organized than that shown in Figure 5Q-S. The phenotype shown, that of ectopic IHC occurring in a single row, seems to indicate a problem with border formation, rather than an overproliferation phenotype?

We agree with the reviewer that defects in border formation could attribute to ectopic IHCs. However, as shown in much detail we observe that FST overexpression disrupts the medial-to-lateral gradient of cell cycle exit, disrupting the proportion of inner and outer hair cell that are being produced.

> Reviewer \#3:
>
> \[...\] Essential revisions:
>
> In McCullar et al., 2010, the study demonstrated that the addition of Activin A to post-hatch avian auditory sensory epithelium increases proliferation while inhibiting the Activin receptors Acvr2a and 2b results in a decrease in proliferation in the sensory epithelium. This significantly lessens the novelty/impact/advance of the current study. It is unfortunate that the authors did not reference this paper.

McCullar et al. investigated the role of Activin signaling in the mature chicken auditory organ. We disagree with the reviewer's view that the aforementioned study lessens the impact of our current study. The study was conducted in explanted adult chicken tissue examining the role of Activin signaling in regenerative supporting cell proliferation-a process that does not exist in mammals. More importantly, Activin signaling in mature chicken auditory sensory epithelium promotes supporting cell (progenitor cell) proliferation, whereas in the developing murine cochlea Activin signaling promotes progenitor cell differentiation. The striking differences in Activin's function in the avian and mammalian auditory organ are quite intriguing and we added a brief discussion of the different roles of Activin signaling in birds and mammals in the Discussion section.

> Furthermore, in the 2010 study McCullar et al., also demonstrated the expression patterns of the Activin receptors Acvr2a and 2b as well as the downstream Smad effector proteins pSmad2 and pSmad1/5/8 in the mammalian cochlea and vestibule (Figure 11, Figure 12, Figure 13 and Figure 14 and Table 4).

The mentioned expression data relates to adult stages and thus has little bearing on the role of Activin signaling during development.

> The expression patterns presented in Figure 1 have been previously published as well. Specifically, the expression of Inhba and Fst have been published by Son et al., 2015 at E13.5 (Figure S5), E15.5 (Figure 5) and E18.5 (Figure S6) clearly demonstrating the spatiotemporal basal-to-apical expression of these two molecules. The Atoh1 and Sox2 expression patterns have also been previously published by many groups including the current authors. Thus, Figure 1 does not offer any significant new information.

The purpose of Figure1 is to characterize Atoh1, Inhba and Fst expression at the onset of hair cell differentiation, which the aforementioned study did not provide.

\[Editors\' note: the author responses to the re-review follow.\]

> The authors have done a very nice job of addressing the reviewers\' comments. There are a few remaining suggestions from the reviewers. The further experimental work suggested by reviewer 1 is left to the authors\' discretion.

We thank our two reviewers and our editors Marianne Bronner (Senior Editor) and Tanya Whitfield (Reviewing Editor) for the favorable evaluation of our revised article. Please see below our response to the reviewer's suggestions:

> Reviewer \#1:
>
> This is a re-submission by Prajapati-DiNublia et al., examining the role of Activin A in hair cell differentiation.
>
> I was not suggesting electrophysiological experiments which I agree would be beyond the scope of this study; rather FM1-43 uptake which would provide evidence of channel/stereociliary function. Furthermore, performing immunohistochemistry to demonstrate innervation phenotypes (if any) is straight forward and would add value to the study.
>
> Lastly, I do agree with the other reviewer that quantification of P-SMAD should include controls showing total receptor protein using antibodies against the un-phosphorylated SMAD form. This would control for changes in total protein levels.

We appreciate the reviewer's suggestions. As the suggested experiments are not essential and to not further delay the publication of the manuscript, we decided to not conduct additional experimental work.

[^1]: Department of Cell and Developmental Biology, The Rocky Mountain Taste and Smell Center University of Colorado, Aurora, United States.

[^2]: These authors contributed equally to this work.
